Device Trial Protocol Optimization
Optimize clinical device trial protocols for FDA/ICH compliance and faster enrollment
What You Can Do
Design, validate, and refine clinical device trial protocols that meet FDA and ICH regulatory requirements. You'll receive detailed protocol structure, endpoint validation matrices, statistical power analysis, and enrollment strategy recommendations that accelerate patient recruitment while maintaining compliance.
Features
Validates protocol against FDA Form 1571 (IND), ICH-GCP E6(R2), and device-specific guidance documents (21 CFR Part 812). Identifies gaps in safety monitoring, informed consent, and risk mitigation strategies.
Develops primary and secondary endpoint hierarchies with statistical success criteria, patient-reported outcome mappings, and superiority/non-inferiority justifications aligned with regulatory precedent.
Analyzes target population demographics, inclusion/exclusion criteria scope, and site selection criteria. Recommends enrollment incentive structures, recruitment channels, and retention tactics based on device category and patient population.
Structures data safety monitoring board (DSMB) charters, serious adverse event (SAE) reporting timelines, and interim analysis plans. Defines stopping rules and escalation criteria for device malfunctions.
Calculates sample size with effect size justification, dropout assumptions, and subgroup analysis plans. Provides power tables and sensitivity analysis for regulatory submission.
Structures head-to-head comparisons with predicate devices or standard-of-care treatments. Develops non-inferiority margin justifications and crossover/washout period recommendations.
Produces site investigator training curricula covering device operation, protocol compliance checkpoints, data collection standards, and regulatory documentation requirements.
Example Output
Primary Endpoint Validation Matrix
| Endpoint | Success Criterion | Measurement Method | Timing | Regulatory Justification |
|---|---|---|---|---|
| Device Patency (Primary) | ≥90% maintained at 6 months | Imaging + clinical assessment | Month 1, 3, 6 | Aligned with predicate device clinical data; 10% non-inferiority margin accepted by FDA |
| Quality of Life (Co-primary) | ≥15 point improvement on SF-36 | Patient-reported questionnaire | Baseline, Month 3, 6 | Published MID for device indication |
Sample Size Calculation
- Primary analysis: 280 patients (2-arm superiority)
- Effect size assumption: 20% absolute difference (80% vs 60%)
- Statistical power: 85% (one-sided α=0.025)
- Dropout assumption: 12% by Month 6
- Subgroup analyses: Pre-specified by device implant location and patient age
Enrollment Strategy Recommendations
- Target sites: 18-24 high-volume centers (≥50 eligible patients annually)
- Patient incentive: $100 gift card per follow-up visit (industry standard for 6-month commitment)
- Recruitment channels: Cardiologist networks, patient registries, direct mail to high-prevalence zip codes
- Projected timeline: 18-month enrollment window with 4-month enrollment buffer
What's Included
- Protocol Architecture Template: Complete protocol outline with required sections: background, rationale, objectives, endpoints, study design, population criteria, safety monitoring, statistical analysis plan, and regulatory submission roadmap.
- Regulatory Alignment Checklist: Compliance verification against FDA guidance (device-specific), ICH-GCP E6(R2), and 21 CFR Part 312 (investigational device exemptions). Flags high-risk areas needing pre-submission meetings.
- Statistical Analysis Plan (SAP) Framework: Pre-specified analysis including sample size justification, primary/secondary efficacy analyses, safety analyses, subgroup specifications, and handling of missing data. Ready for regulatory submission.
- Enrollment & Site Selection Workbook: Demographics-based enrollment projections, site capability assessment rubric (investigator experience, patient population, infrastructure), and recruitment timeline gantt charts.
- Data Safety Monitoring Board Charter Template: DSMB governance structure, charter language, meeting frequency, stopping rules, and SAE escalation procedures. Includes sample serious adverse event decision trees.
- Endpoint Justification Dossier: Literature review summaries supporting endpoint selection, minimal clinically important differences (MCID), and regulatory precedent for similar device approvals.
Who It's For
- Clinical Trial Managers
- Regulatory Affairs Specialists
- Biostatisticians
- Medical Device Company Directors
- Clinical Research Coordinators
Best For
- Designing FDA submissions for Class II/III medical devices
- Optimizing patient enrollment and retention strategies
- Validating efficacy endpoints against regulatory precedent
- Structuring comparative effectiveness trials
You might also like
You'll design and optimize observational study protocols from conception through regulatory documentation. The skill guides you through identifying and quantifying confounders, selecting appropriate study designs (cohort, case-control, cross-sectional), implementing bias mitigation strategies, and generating publication-ready protocols that meet regulatory standards.
by hah23255
You can design comprehensive clinical trial protocols that meet FDA and ICH-GCP requirements, develop rigorous patient eligibility criteria, and establish safety monitoring frameworks that protect trial participants. This skill helps you assess inclusion/exclusion criteria, define safety endpoints, plan statistical analyses, and generate regulatory-ready documentation—accelerating protocol development from concept to submission-ready draft.
by hah23255
You get expert guidance developing NSF-aligned healthcare research proposals from strategic positioning through final compliance. Claude analyzes your research concept against NSF priorities, structures a competitive narrative, justifies budget allocations, and ensures all compliance requirements (biosketch, data management plans, institutional review) are met. The result is a cohesive, review-ready proposal that increases your chances of NSF funding.
by hah23255
You structure clinical research manuscripts according to IMRaD (Introduction, Methods, Results, Discussion) standards required by peer-reviewed journals. This skill helps you draft sections from raw research notes, polish prose for academic clarity, enforce citation standards, and identify common submission issues before sending to journals. The result is a manuscript ready for peer review with minimal editor feedback.
by hah23255
Create fully-accredited continuing medical education programs with learning objectives, educational content, assessments, and evaluation materials that meet ACCME and ANCC standards. This skill automates compliance validation, ensures proper alignment between objectives and content, and generates all required accreditation documentation in minutes instead of weeks.
by hah23255
This skill guides you through the complete statistical workflow for genomic research—from study design and sample size determination to analysis method selection and result interpretation. You get evidence-based recommendations for handling genomic data's unique challenges: multiple testing correction, batch effects, and small-sample inference. Each recommendation includes the reasoning, assumptions, and limitations so you can make informed choices for your research.
by hah23255
Analyze ingredient costs across your recipes and menus to identify profitability gaps and optimization opportunities. You'll receive detailed cost breakdowns, margin analysis by dish, and data-driven recommendations for pricing strategy, portion sizes, and ingredient substitutions that maintain your culinary standards while improving your bottom line.
by hah23255
You can systematically review research protocols against ethical frameworks, regulatory standards, and risk-benefit principles. This skill identifies compliance gaps, assesses risks to human or animal subjects, evaluates scientific merit against potential harms, and generates structured compliance reports that support institutional review board (IRB) decisions and regulatory submissions.
by hah23255